Reversible monoamine oxidase type A (MAO-A) inhibitor. Prepn: F. X. Jarreau et al., EP 424244; eidem, US 5036091 (1990, 1991 both to Delalande). Pharmacology: D. Caille et al., J. Pharmacol. Exp. Ther. 277, 265 (1996). Biochemical profile: O. Curet et al., ibid. 253. Structure-activity study: J. Wouters et al., Bioorg. Med. Chem. 7, 1683 (1999). Review of clinical pharmacology: P. Rosenzweig et al., J. Affect. Disord. 51, 305-312 (1998).
Antidepressant.
Monoamine Oxidase Inhibitor; Antidepressant; Phenyloxazolidinones